Adaptive Biotechnologies Corp (ADPT) — Capital Reinvestment Ratio
Latest as of March 2019:
0.01x
Adaptive Biotechnologies Corp (ADPT) has a Capital Reinvestment Ratio of 0.01x as of March 2019, meaning it reinvests 0% of its operating cash flow ($278.30 Million) in capital expenditures ($3.83 Million). See ADPT FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$278.30 Million
USD
Capital Expenditures
$3.83 Million
USD
Data as of
Mar 2019
Most recent filing
Adaptive Biotechnologies Corp Capital Reinvestment Ratio (2019–2019)
This chart tracks Adaptive Biotechnologies Corp's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Adaptive Biotechnologies Corp (2019–2019)
Year-by-year Capital Reinvestment Ratio for Adaptive Biotechnologies Corp from 2019 to 2019. For live market cap and broader valuation context, see market cap of Adaptive Biotechnologies Corp.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.05x | $205.40 Million | $11.20 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow